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India and to detect the role of pmrB and arnA genes in resistant
phenotype.
Methods & Materials: Methods and Materials: Consecutive
non-duplicate clinical isolates of Pseudomonas aeruginosa were
collected from the patients admitted to surgical ward of Silchar
Medical College and Hospital in the duration of September 2013 to
August 2014. The isolates were screened for polymyxin resistance
by Kirby-Bauer disc diffusion method and the minimum inhibitory
concentrations. mRNA and cDNA of ﬁve selected polymyxin resis-
tant strains representing different MIC range were isolated in
normal condition of the strain as well as after treating with Fecl3
alone and Fecl3 and polymyxin antibiotic. Transcriptional expres-
sion was observed for pmrB and arnA by quantitative real time PCR
in reference to P. aeruginosa PAO1. Susceptibility pattern of these
polymyxin resistant strainswasperformedbyKirby- Bauer disc dif-
fusion method. DNA ﬁngerprinting of the isolates was carried out
by performing REP PCR.
Results: Results: A down regulated expression of pmrB and
arnA was observed in polymyxin resistant strains of P.aeruginosa
which is unique comparing to other studies. Low suscepti-
bility rate to amikacin and gentamicin, -lactam--lactamase
inhibitor piperacillin-tazobactam and quinolone group of drug
ciproﬂoxacin was shown by polymyxin resistant P.aeruginosa
strains whereas total resistance was observed in case of third gen-
eration cephalosporin cefepime. REP PCR results showed these
polymyxin resistant organisms are heterogenous by showing dif-
ferent clonal pattern.
Conclusion: Conclusion: This study highlights the urgency of
obtaining knowledge on the pharmacology of polymyxins to opti-
mize their clinical use and minimize potential for development of
resistance. Thiswill help inmanagement of treatment and infection
control due to multidrug resistant P. aeruginosa.
http://dx.doi.org/10.1016/j.ijid.2016.02.239
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Background: Multidrug-resistant (MDR) A. baumannii has been
a serious challenge in the hospitals globally including Bangladesh.
The study was performed to investigate molecular epidemiology
& spread dynamics of antibiotic resistant A. baumannii both from
patients and hospital environment in Bangladesh.
Methods & Materials: A set of 49 clinical Acinetobacter strains
were collected from ﬁve clinical microbiology labs located in
Dhaka, Bangladesh during 2014-2015. Additionally, 100 samples
were collected from different hospital surfaces of Dhaka Medi-
cal College Hospital. All strains and samples were cultured on
CHROMagarTM Acinetobacter selective media. A. baumannii was
identiﬁedat species level bybiochemical tests&blaOXA-51PCR.Resis-
tance to 13 antibiotics under different 8 classes was determined
according to EUCAST and CLSI. PCR was used to detect differ-
ent resistance genes; quinolones (qnrS1, aac6, qepA, qnrC1, qnrB1,
qnrA1), 16S methylase (rmtA,rmtB, rmtC, rmtD, armA)and OXAs(-
23,-24,-58,-143). Real-time multiplex PCR were conducted for the
presence of carbapenem resistant genes (NDM, VIM, IMP, KPC and
oxa-48). Epidemiological typing & clonal proﬁle was performed by
rep-PCR.
Results: 95% (47/49)humanand31% (10/32) environmental iso-
lates of A. baumannii had growth on CHROMagarTM agar. All clinical
and 10 environmental strains carried blaOXA-51 gene which con-
ﬁrmed as A. baumannii. Resistance to 4 or more antibiotic classes
was found in 48 clinical and 10 environmental strains. Forty clinical
and all environmental strains carried blaOXA-23 however; blaOXA-58
was in one clinical strain. The predominant ciproﬂoxacin resistant
gene was aac6in both clinical and environmental isolates followed
by qnrB1in clinical isolates and qnrC1in environmental isolate. Only
armA gene was found in clinical and environmental strains. None
of the clinical and environmental strains were positive for other
carbapenem resistant genes (NDM, VIM, IMP, KPC, OXA-48). In total,
36 different clones were identiﬁed from both patients and envi-
ronment; 6 different clinical clones (AC, BC, DC, FC, HC, PC) were
common in different hospitals among patients. Some of the clones
(CC, RC, P3, P6) were common both in patients and environmental
strains.
Conclusion: The magnitude of resistance including their phe-
notypes and genotypes, and clonal relatedness among clinical and
environmental A. baumannii indicates multi-drug resistant strains
were wide spread in Bangladeshi hospitals.
http://dx.doi.org/10.1016/j.ijid.2016.02.240
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Background: The epidemiological situation of tuberculosis in
Ukraine is extremely unfavorable – about 40 thousand people
become sick on tuberculosis each year and about 10 thousand
patients die. Changing of the contemporary socio-economic and
environmental conditions plays an important role in the dete-
rioration of the tuberculosis epidemic situation. Moreover drug
resistance of M.tuberculosis is one of the main factors limiting the
effectiveness of TB treatment. Due to the development of molec-
ular genetics it has become possible to conduct genetic typing of
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bacteria, which allows distinguishing between different strains of
the pathogen isolated from TB patients.
Methods & Materials: During 2014 the 93 cases of TB were
studied in patients who were treated in hospitals in Kharkiv region
in Ukraine. Mycobacterium identiﬁcation and testing of the drug
susceptibility were performed as recommended by WHO. The
samples of expectoration were used for the strain isolation on
Lowenstein-Jensen medium. VNTR genotyping was done by using
sets of primers for ampliﬁcation of ﬁve exact tandem repeat ETR
loci as previously described (Frothingham, R., 1998).
Results: It hasbeen shown that 69% from isolatedM. tuberculosis
strains belong to Beijing family whereas 13% –to LAM. Other geno-
types consisted 18% from all obtained isolates. The most common
proﬁle was 42435.
The most common resistance among Beijing strains were
observed to streptomycin (100%), followed by resistance to isoni-
azid (99%), rifampicin (96%) and ethambutol (89%). Kanamycin and
oﬂoxacin did not inhibit growth of M. tuberculоsis isolates in 69%
and 60% cases respectively. The most effective anti-TB drug was
cycloserine (10%). Among LAM strains it was found resistance to
kanamycin, isoniazid and streptomycin in 12 (100%) cases, etham-
butol and rifampicin – in 11 (91.5%) cases.
The frequency of resistance to kanamycin, 4-Aminosalicylic acid
and ethionamide was revealed signiﬁcantly higher for LAM strain
in compare to Beijing strain (p <0.05). 41 (44%) of 93 patients were
diagnosed as MDR TB and 52 (56%) – TB with extending resistance.
Conclusion: In conclusion, the data showed that TB in Kharkiv
region is mostly characterized as multi-drug resistance cases. To
prevent circulation and transmission of M.tuberculosis TB control
program needs to be improved in Ukraine.
http://dx.doi.org/10.1016/j.ijid.2016.02.241
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Background: Microorganisms though dimunuitive are
formidable foes. The antibiotic soup that now permeates health-
care facilities has exerted a selection pressure on pathogens and
commensal organisms alike, and resistance has proliferated and
spread such that many bacteria can withstand almost all drugs.
Detection of -lactamases by virtue of their diverse complex-
ity is a diagnostic dilemma hindered by the heterogeneity of both
host and enzyme. Expression of multiple -lactamases and their
co-existence is a common parlance particularly in nosocomial
pathogens which are notorious for disseminating them compro-
mising the therapeutic alternatives. When faced with this mélange
of enzymes in resource constraint settings lack or inadequacy of
diagnostic tests may have grave implications.
Methods & Materials: 168 clinical isolates E.coli (n =53)
K.pneumoniae (n =115) from invasive site infections were studied
for their antimicrobial susceptibility and detection of -lactamase
by inhibitor based disc potentiation test (DPT). A total of 18 agents
of which 6 were substrate inhibitor combination discs were tested
per isolate. Detection of ESBL, MBL, AmpC and KPC was done by
using inhibitors- EDTA, Dipicolinic acid (DCA), Phenyl boronic acid
(PBA), Clavulanic acid (CA) and cloxacillin(CLOX). Appropriate con-
trols were incorporated.
Results: High resistance to all classes of cephalosporins was
observed inall isolates. Carbapenemresistancewas found in87.15%
isolates. Least resistance to cotrimoxazole andgentamicinwas seen
among the antimicrobials tested. ESBL was the most frequent 
lactamase detected followed by MBL>AmpC>KPC.
Conclusion: We are living in a world where we will never be
able to stay ahead of the bacterial mutation curve. A test of our
resilience is how far behind the curve we allow ourselves to fall.
Limiteddata is availableonpresenceofKPC’s in India andnone from
our region. There is a need for enhanced adherence with effective
infection control measures, detect and protect strategy and antibi-
otic stewardship to curb patient-to-patient transmission and to
reduce the selection of multidrug-resistant bacteria. Currently the
main issues are providing practical recommendations ondetection,
treatment and prevention in different resources settings.
http://dx.doi.org/10.1016/j.ijid.2016.02.242
